Formulated for insomnia to manage sleep duration and support effective rest cycles.
Mechanism of Action
The medication enhances the effect of GABA by binding to the GABA-A receptor complex. This increases inhibitory neurotransmitter activity in the brain, which facilitates falling asleep and remaining asleep throughout the night.
Route of Administration
Oral
Onset Time
15–30 minutes
Duration
7–8 hours
Contraindications
History of complex sleep behaviors, Severe hepatic impairment, Hypersensitivity to eszopiclone
Severe Adverse Events
Complex sleep behaviors, Anaphylaxis, Severe depression — requires immediate medical attention
Common Side Effects
Metallic taste, Drowsiness, Dry mouth
Uncommon Side Effects
Headache, Dizziness, Nausea
Drug Interactions
Alcohol, Ketoconazole, Rifampin, Diazepam
Pregnancy Safety Warnings
FDA Category C: Use with caution. Breastfeeding: Excretion in milk is unknown.
Information related to Fulnite is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
